The Wall Street Journal: "Former Novartis Pharma-Unit Head Joins Venture-Capital Firm"

Today, we announced that David Epstein, former CEO of Novartis, has joined Flagship Pioneering in the newly-created role of executive partner. Denise Rowland from the Wall Street Journal spoke with David and Noubar Afeyan, Flagship's CEO, about the move and the trend of industry executives moving into the venture and startup industry. Read the full story: http://on.wsj.com/2j4eq01